1-(3-chloropropyl)-4-methylpiperazine,dihydrochloride | CAS:2031-23-4

We serve 1-(3-chloropropyl)-4-methylpiperazine,dihydrochloride CAS:2031-23-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-(3-chloropropyl)-4-methylpiperazine,dihydrochloride

Chemical Name:1-(3-chloropropyl)-4-methylpiperazine,dihydrochloride
CAS.NO:2031-23-4
Synonyms:1-(3-chloropropyl)-4-methylpiperazine,dihydrochloride
1-(3-Chloropropyl)-4-methylpiperazine dihydrochloride
 
Physical and Chemical Properties:
Boiling Point 242.9ºC at 760 mmHg
Molecular Formula C8H19Cl3N2
Molecular Weight 249.609
Flash Point 100.7ºC
 
Specification:
Appearance:White crystal
Assay:≥98.0%
Moisture:≤2.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Bosutinib(CAS:380843-75-4).



Contact us for information like 1-(3-chloropropyl)-4-methylpiperazine,dihydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(3-Chloropropyl)-4-methylpiperazine dihydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(3-Chloropropyl)-4-methylpiperazine dihydrochloride Use and application,1-(3-Chloropropyl)-4-methylpiperazine dihydrochloride technical grade,usp/ep/jp grade.


Related News: Their pharmacological activity plays a direct role in the diagnosis, cure, mitigation, treatment, or prevention of disease.Vitamin A palmitate manufacturer Their pharmacological activity plays a direct role in the diagnosis, cure, mitigation, treatment, or prevention of disease.1-(bromomethyl)-2-(trifluoromethyl)benzene supplier With the continuous accumulation of the API industry and the increasing maturity of the market, competition in China’s API industry will become increasingly fierce.6-aminopyridine-2-carboxylic acid vendor In recent years, the government has heavily promoted TCM, as part of efforts by Xi to bolster the country’s health sector and fill the gaps in national insurance schemes.In recent years, the government has heavily promoted TCM, as part of efforts by Xi to bolster the country’s health sector and fill the gaps in national insurance schemes.